Ex Vivo Corneal Organ Culture Model for Wound Healing Studies
نویسندگان
چکیده
منابع مشابه
A novel ex vivo model of equine corneal wound healing
Corneal disease is a significant cause of decreased vision or blindness in the horse worldwide. Numerous topical and systemic drugs over a prolonged period of time may be used to treat an equine corneal ulcer. Despite the high prevalence of corneal disease and ulceration in the horse, and the complexity of corneal wound healing, research is limited and more heavily devoted to in vivo studies wh...
متن کامل2417 A simple organ culture model for corneal wound healing studies: The effect of growth factors
Purpose: Tenascin is an extracellular matrix glycoprotein which is expressed transiently in wound healing in human skin and animal corneas. In virro and ednbryological studies suggest that tenascin mediates cell adhesion/anti-adhesion, enhancunen~mlubltion of cell proliiation, and promotion of cell migration. At present there are no published data regarding human comeal wound healing, therefore...
متن کاملComparison of interleukin 10 homologs on dermal wound healing using a novel human skin ex vivo organ culture model.
BACKGROUND Anti-inflammatory cytokine interleukin (IL)-10 has been shown to induce regenerative healing in postnatal wounds. A viral homolog of IL-10 produced by human cytomegalovirus (CMV IL-10) similarly generates potent immunoregulatory effects, but its effects on wound healing have not been investigated. Currently, there are limited cost-effective methods of screening vulnerary therapeutics...
متن کاملAlbumin precursor and Hsp70 modulate corneal wound healing in an organ culture model.
In order to investigate the role of albumin precursor and Hsp70 in corneal wound healing, we have analyzed the distribution of these proteins in wounded and non-wounded corneas of rabbits and the effects of topical applications of anti-albumin precursor and anti-Hsp70 antibodies on wound healing. Anti-albumin precursor and anti-Hsp70 antibodies were topically applied in healing corneal epitheli...
متن کاملEx vivo corneal epithelial wound healing following exposure to ophthalmic nonsteroidal anti-inflammatory drugs
PURPOSE Ketorolac 0.45% is a new formulation of topical ketorolac in which preservative (benzalkonium chloride, BAK) was removed and carboxymethylcellulose (CMC) was added to improve tolerability and reduce dosing frequency. This study compared the effects of ketorolac 0.45% on corneal wound healing to prior ketorolac formulations (0.4% and 0.5%), bromfenac 0.09%, and nepafenac 0.1%. METHODS ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Visualized Experiments
سال: 2019
ISSN: 1940-087X
DOI: 10.3791/58562